Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes is a research paper published in Frontiers in Cardiovascular Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 78 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Diabetes Association
Grant: 1-16-IBS-153
National Institutes of Health
Grant: DK076169
National Institutes of Health
Grant: DK115255 (P&F to JK)
National Institutes of Health
Grant: DP3DK108209
National Institutes of Health
Grant: R01HL127694
National Institutes of Health
Grant: R01HL126028
National Institutes of Health
Grant: P01HL092969
National Institutes of Health
Grant: R21AI135447 (KB)
Diabetes Research Center
Grant: P30DK017047
National Institutes of Health
Grant: 1R21AI135447-01
Probing human leukocytes to target inflammatory macrophage proliferation in chronic inflammation
National Institutes of Health
Grant: 5P01HL092969-55
Cardiovascular Disease and Diabetes Program Project
National Institutes of Health
Grant: 3P30DK017047-26S2
CORE--CELL AND TISSUE CULTURE FACILITY
National Institutes of Health
Grant: 5P01HL092969-49
Role of Serum Amyloid A in Diabetic Vascular Disease
National Institutes of Health
Grant: 3U24DK115255-02S1
Coordinating Unit for DiaComp
National Institutes of Health
Grant: 5R01HL127694-03
Proteolytic control of local inflammatory macrophage proliferation
National Institutes of Health
Grant: 3U24DK076169-08S3
Coordinating and Bioinformatics Unit for the DCC/MMPC
National Institutes of Health
Grant: 1DP3DK108209-01
APOC3, HDL Function and Cardiovascular Complications of T1DM
National Institutes of Health
Grant: 2P30DK017047-42
Diabetes Research Center
National Institutes of Health
Grant: 5R01HL126028-04
Obesity and Arterial Metabolism
NIAID NIH HHS
Grant: R21 AI135447
Influential Citations
1
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Additional file 1 of BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Additional file 2 of BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Additional file 2 of BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Additional file 1 of Dysregulation of long non-coding RNA gene expression pathways in monocytes of type 2 diabetes patients with cardiovascular disease
Additional file 1 of Dysregulation of long non-coding RNA gene expression pathways in monocytes of type 2 diabetes patients with cardiovascular disease